Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orbis Investment Management is a global asset management firm founded in 1989 by Allan Gray. Headquartered in Bermuda, the firm employs a contrarian, fundamental, long-term value investment philosophy across global equity markets. While a generalist investor, Orbis maintains significant exposure to the healthcare and life sciences sectors through large institutional equity positions in major pharmaceutical, biotechnology, and managed care companies. The firm is recognized for its unique performance-based fee structure and its ownership by the Allan & Gill Gray Foundation, which ensures its long-term independence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orbis Funds Management.